METHODS We conducted a systematic study which represents one of the most
comprehensive effort to quantify global HCV epidemiology, using the best available …

Background The burden of hepatitis C virus (HCV) infection is escalating among people who
inject drugs (PWID), yet testing and treatment remains suboptimal. The aim of this systematic …

Under the terms of this licence, you may copy, redistribute and adapt the work for
noncommercial purposes, provided the work is appropriately cited, as indicated below. In …

The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …

Elimination of HCV as a public health concern among people w... : African Journal of
Reproduction and Gynaecological Endoscopy Elimination of HCV as a public health concern …

All-oral direct-acting antiviral drugs (DAAs) for hepatitis C virus, which have response rates
of 95% or more, represent a major clinical advance. However, the high list price of DAAs has …

Globally, 12 million people are estimated to have injected drugs in the past year, 50% of
whom have chronic HCV infection, with people who have previously injected drugs …

Introduction: The availability of simple, tolerable, therapies for hepatitis C virus (HCV)
infection with responses> 95% is one of the greatest medical advances in decades, offering …

Background Point-of-care hepatitis C virus (HCV) RNA testing offers an advantage over
antibody testing (which only indicates previous exposure), enabling diagnosis of active …

Point-of-care hepatitis C virus (HCV) RNA testing is advantageous, enabling diagnosis of
active infection in a single visit. This study evaluated the sensitivity and specificity of the …